Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 3,597 | 3,763 | 4,140 | 4,481 | 4,514 |
| Gross Profit | 3,550 | 3,640 | 4,250 | 4,550 | 4,400 |
| Operating Expenses | 6,170 | 5,730 | 5,960 | 8,280 | 7,520 |
| Operating Income | -2,573 | -1,967 | -1,820 | -3,799 | -3,006 |
| Other Income | -577 | 177 | 320 | 149 | -134 |
| Pre-tax Income | -3,150 | -1,790 | -1,500 | -3,650 | -3,140 |
| Net Income Continuous | -3,197 | -1,852 | -1,480 | -3,591 | -3,219 |
| Net Income | $-3,197 | $-1,852 | $-1,480 | $-3,591 | $-3,219 |
| EPS Basic Total Ops | -0.25 | -0.15 | -0.12 | -0.34 | -0.31 |
| EPS Basic Continuous Ops | -0.25 | -0.15 | -0.12 | -0.34 | -0.31 |
| EPS Diluted Total Ops | -0.25 | -0.15 | -0.12 | -0.34 | -0.31 |
| EPS Diluted Continuous Ops | -0.25 | -0.15 | -0.12 | -0.34 | -0.31 |
| EBITDA(a) | $-2,333 | $-1,727 | $-1,570 | $-3,549 | $-2,766 |